| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RVNC | Revance Therapeutics, Inc. | Ruegg Curtis | EVP, Technical Operations | Jun 13, 2016 | Option Exercise | $13.47 | 2,000 | 26,950 | 24,944 | Jun 15, 2016, 07:29 PM | |
| RVNC | Revance Therapeutics, Inc. | Ruegg Curtis | EVP, Technical Operations | May 19, 2016 | Option Exercise | $17.11 | 1,320 | 22,585 | 23,944 | May 23, 2016, 09:25 PM | |
| RVNC | Revance Therapeutics, Inc. | Ruegg Curtis | EVP, Technical Operations | May 09, 2016 | Sale | $12.44 | 2,000 | 24,880 | 26,264 | May 11, 2016, 06:42 PM | |
| RVNC | Revance Therapeutics, Inc. | Ruegg Curtis | EVP, Technical Operations | Apr 11, 2016 | Sale | $13.91 | 2,000 | 27,810 | 26,264 | Apr 13, 2016, 06:59 PM | |
| RVNC | Revance Therapeutics, Inc. | Ruegg Curtis | EVP, Technical Operations | Mar 07, 2016 | Sale | $14.57 | 2,000 | 29,130 | 26,264 | Mar 09, 2016, 06:46 PM | |
| RVNC | Revance Therapeutics, Inc. | Ruegg Curtis | EVP, Technical Operations | Feb 08, 2016 | Sale | $13.42 | 2,000 | 26,840 | 18,264 | Feb 10, 2016, 08:50 PM | |
| RVNC | Revance Therapeutics, Inc. | Ruegg Curtis | EVP, Technical Operations | Jan 28, 2016 | Option Exercise | $20.30 | 763 | 15,489 | 17,264 | Feb 01, 2016, 06:53 PM | |
| RVNC | Revance Therapeutics, Inc. | Ruegg Curtis | EVP, Technical Operations | Jan 06, 2016 | Sale | $20.88 | 4,000 | 83,520 | 20,027 | Jan 08, 2016, 06:56 PM | |
| RVNC | Revance Therapeutics, Inc. | Ruegg Curtis | EVP, Technical Operations | Aug 17, 2015 | Sale | $19.52 | 6,000 | 117,090 | 21,027 | Aug 19, 2015, 08:01 PM | |
| RVNC | Revance Therapeutics, Inc. | Ruegg Curtis | EVP, Technical Operations | Jul 17, 2015 | Option Exercise | $19.22 | 6,000 | 115,334 | 21,027 | Jul 21, 2015, 08:11 PM | |
| RVNC | Revance Therapeutics, Inc. | Ruegg Curtis | EVP, Technical Operations | Jun 17, 2015 | Sale | $20.07 | 6,000 | 120,393 | 21,027 | Jun 19, 2015, 07:01 PM | |
| RVNC | Revance Therapeutics, Inc. | Ruegg Curtis | EVP, Technical Operations | Jun 03, 2015 | Option Exercise | $18.30 | 1,000 | 18,300 | 18,527 | Jun 05, 2015, 07:06 PM | |
| RVNC | Revance Therapeutics, Inc. | Ruegg Curtis | EVP, Technical Operations | May 19, 2015 | Option Exercise | $25.94 | 1,310 | 33,981 | 18,027 | May 21, 2015, 06:55 PM | |
| RVNC | Revance Therapeutics, Inc. | Ruegg Curtis | EVP, Technical Operations | May 15, 2015 | Option Exercise | $15.80 | 1,000 | 15,800 | 19,837 | May 19, 2015, 07:25 PM | |
| RVNC | Revance Therapeutics, Inc. | Ruegg Curtis | EVP, Technical Operations | May 18, 2015 | Sale | $16.65 | 5,000 | 83,247 | 21,837 | May 19, 2015, 07:25 PM | |
| RVNC | Revance Therapeutics, Inc. | Ruegg Curtis | EVP, Technical Operations | Apr 17, 2015 | Option Exercise | $14.42 | 4,000 | 57,667 | 20,340 | Apr 21, 2015, 06:54 PM | |
| RVNC | Revance Therapeutics, Inc. | Ruegg Curtis | EVP, Technical Operations | Mar 19, 2015 | Option Exercise | $13.30 | 1,000 | 13,300 | 19,837 | Mar 23, 2015, 06:09 PM | |
| RVNC | Revance Therapeutics, Inc. | Ruegg Curtis | EVP, Technical Operations | Mar 17, 2015 | Option Exercise | $12.61 | 3,000 | 37,815 | 20,837 | Mar 19, 2015, 06:09 PM | |
| RVNC | Revance Therapeutics, Inc. | Ruegg Curtis | EVP, Technical Operations | Mar 09, 2015 | Sale | $12.30 | 1,000 | 12,300 | 19,837 | Mar 11, 2015, 06:36 PM | |
| RVNC | Revance Therapeutics, Inc. | Ruegg Curtis | EVP, Technical Operations | Feb 17, 2015 | Sale | $11.36 | 2,000 | 22,711 | 20,337 | Feb 18, 2015, 07:53 PM | |
| RVNC | Revance Therapeutics, Inc. | Ruegg Curtis | EVP R&D and Tech Operations | Jan 20, 2015 | Sale | $9.90 | 2,000 | 19,800 | 15,106 | Jan 22, 2015, 07:18 PM | |
| RVNC | Revance Therapeutics, Inc. | Ruegg Curtis | EVP R&D and Tech Operations | Jan 09, 2015 | Sale | $10.27 | 1,000 | 10,275 | 14,606 | Jan 13, 2015, 06:55 PM | |
| RVNC | Revance Therapeutics, Inc. | Ruegg Curtis | EVP R&D and Tech Operations | Dec 17, 2014 | Option Exercise | $9.50 | 2,000 | 19,000 | 15,106 | Dec 19, 2014, 05:25 PM | |
| RVNC | Revance Therapeutics, Inc. | Ruegg Curtis | EVP R&D and Tech Operations | Dec 09, 2014 | Option Exercise | $10.27 | 1,000 | 10,275 | 14,606 | Dec 11, 2014, 06:35 PM | |
| RVNC | Revance Therapeutics, Inc. | Ruegg Curtis | EVP R&D and Tech Operations | Nov 18, 2014 | Option Exercise | $9.27 | 2,000 | 18,550 | 15,106 | Nov 20, 2014, 08:33 PM | |
| RVNC | Revance Therapeutics, Inc. | Ruegg Curtis | EVP R&D and Tech Operations | Oct 28, 2014 | Option Exercise | $11.27 | 1,000 | 11,275 | 13,768 | Oct 30, 2014, 08:00 PM | |
| RVNC | Revance Therapeutics, Inc. | Ruegg Curtis | EVP R&D and Tech Operations | Oct 17, 2014 | Option Exercise | $10.55 | 3,000 | 31,664 | 14,768 | Oct 21, 2014, 06:38 PM | |
| RVNC | Revance Therapeutics, Inc. | Ruegg Curtis | EVP R&D and Tech Operations | Sep 17, 2014 | Sale | $13.93 | 3,162 | 44,061 | 15,268 | Sep 19, 2014, 07:34 PM | |
| RVNC | Revance Therapeutics, Inc. | Ruegg Curtis | EVP R&D and Tech Operations | May 19, 2014 | Option Exercise | $32.22 | 10,500 | 338,310 | 14,106 | May 21, 2014, 09:32 PM |
Menu